Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/21/13 | $10,500,000 | Series A |
Flagship Ventures | undisclosed |
| 06/09/14 | $10,000,000 | Series B |
Alexandria Real Estate Equities Flagship Ventures Mayo Clinic Ventures | undisclosed |
| 12/02/14 | $48,000,000 | Series C |
